MSF challenges Gilead’s unmerited patent in China for lifesaving hepatitis C medicine.
Affordable generic versions from China could save millions of people’s lives.
Read more
Photo by Siddharth Singh
MSF briefing documents for the 71st World Health Assembly (WHA)
THE NAKED TRUTH
The high prices of medicines sometimes stop our medical teams and others from giving the treatment we know can save lives. The pharmaceutical industry says the high prices they charge for medicines are down to the costs of research.
WATCH THE VIDEO
RCEP: A BAD DEAL FOR MEDICINE
The Regional Comprehensive Economic Partnership (RCEP) trade agreement is being negotiated in secret, without input from public health stakeholders. A leaked draft of the negotiating text has revealed some proposed provisions that could undermine access to price-lowering, generic medicines.
LEARN MORE
ACCESS CAMPAIGN YEAR IN REVIEW 2017
We hope you will be inspired by our work and we invite you to join us in our continued efforts to ensure that everyone benefits from modern medicine.
READ MORE
What is the Campaign?
Médecins Sans Frontières set up the Access Campaign in 1999 to push for access to, and the development of life-saving and life prolonging medicines, diagnostic tests and vaccines for patients in MSF programmes and beyond. We are a multi-disciplinary team that includes doctors, pharmacists, scientists, lawyers, as well as advocacy and communications experts. We also work with patient groups and other civil society organisations in response to their concerns over access to treatment.
Stories from the Field
- » HIV in Central African Republic: Patient Stories from Hôpital Communautaire
- » HIV in Central African Republic: "If you provide care, they will come."
- » Snakebite in South Sudan: Little hope of a cure for the most vulnerable
- » South Sudan: The Book that Traveled Too Much
- » Guinea: Screening for HIV in Conakry
- » Pakistan: Stories from patients cured from hepatitis C in MSF's Machar Clinic in Karachi
